PetMed Express, Inc.
PETS
$3.50
-$0.02-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -18.88% | -16.10% | -13.15% | 6.56% | 10.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.88% | -16.10% | -13.15% | 6.56% | 10.95% |
| Cost of Revenue | -19.73% | -17.04% | -10.30% | 7.33% | 8.71% |
| Gross Profit | -16.63% | -13.71% | -20.22% | 4.57% | 17.36% |
| SG&A Expenses | -28.22% | -15.26% | -52.38% | 27.30% | 32.08% |
| Depreciation & Amortization | -10.40% | -3.21% | 2.56% | 90.64% | 88.10% |
| Other Operating Expenses | -- | -- | -- | -416.28% | -- |
| Total Operating Expenses | -21.87% | -16.26% | -21.72% | 11.61% | 15.72% |
| Operating Income | 85.36% | -3.48% | 564.37% | -531.19% | -1,236.52% |
| Income Before Tax | 90.85% | -27.73% | 429.97% | -868.21% | -1,153.55% |
| Income Tax Expenses | 175.24% | -347.96% | 428.08% | 129.60% | -61,900.00% |
| Earnings from Continuing Operations | 65.12% | 225.31% | 430.46% | -2,222.22% | -856.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.12% | 225.31% | 430.46% | -2,222.22% | -856.13% |
| EBIT | 85.36% | -3.48% | 564.37% | -531.19% | -1,236.52% |
| EBITDA | 187.12% | -3.30% | 1,583.07% | -855.15% | -283.40% |
| EPS Basic | 65.42% | 221.65% | 427.37% | -2,215.09% | -853.85% |
| Normalized Basic EPS | 90.98% | -6.05% | 1,226.22% | -5,994.44% | -900.99% |
| EPS Diluted | 65.70% | 266.67% | 400.00% | -2,253.77% | -861.54% |
| Normalized Diluted EPS | 90.98% | -5.66% | 1,203.05% | -5,994.44% | -900.99% |
| Average Basic Shares Outstanding | 1.03% | 1.05% | 0.89% | 0.56% | 0.61% |
| Average Diluted Shares Outstanding | 1.03% | 0.76% | 3.00% | 0.51% | 0.61% |
| Dividend Per Share | -- | -- | -- | -100.00% | -100.00% |
| Payout Ratio | 0.81% | -1.00% | 1.01% | 1.00% | 1.00% |